Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial membrane and thiol-containing bacterial proteins represent a collective set of targets for broad-spectrum antimicrobial agents, most notably silver-based compounds and certain heavy metals. The bacterial cell membrane is a critical structure that maintains osmotic pressure and houses the electron transport chain, while thiol-containing proteins include a vast array of enzymes essential for metabolism, DNA replication, and antioxidant defense (Jung et al., 2008). Antimicrobial agents targeting these sites typically act by binding to sulfhydryl (-SH) groups, leading to the denaturation of proteins and the inactivation of critical metabolic pathways (Feng et al., 2000). Simultaneously, these agents can disrupt the lipid bilayer of the bacterial membrane, causing increased permeability, loss of the proton motive force, and eventual cell lysis (Matsumura et al., 2003). This multi-targeted approach is highly effective against a wide range of pathogens, including antibiotic-resistant strains, making it a staple in topical wound care and surface disinfection. However, because these targets are not unique to a single species and involve fundamental biochemical groups, the lack of high specificity can lead to toxicity in host tissues if systemic exposure is not carefully managed.
Drugs targeting these components exert antimicrobial effects through the high affinity of metal ions (like Ag+ or Hg2+) for sulfhydryl groups, causing protein misfolding and enzymatic inhibition, while concurrently intercalating into the bacterial membrane to induce structural damage and cytoplasmic leakage.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial membrane and thiol-containing bacterial proteins.